Once the ailing part of a family business, Singapore-listed Eu Yan Seng International, is in the pink of health.» Read More
With Obamacare looming, businesses may look to offer employees healthy-living incentives and track them, said John Sculley, co-founder of Misfit Wearables and former Apple CEO.
People who choose to undergo plastic surgery are looking to shave many years off their appearance. A new study has found that the number of years is smaller than you'd expect.
With 76 million baby boomers reaching retirement age over the next decade, the need for long-term care services is expected to surge. What to do?
Thinking ahead about long-term care can bring big benefits later as the experience of a retired New Jersey teacher shows.
Gina Martin Adams, Senior Equity Strategist at Wells Fargo Securities, says there's one sector that will be a bright spot in the months to come.
Working more could mean thousands of dollars less for you under a quirk in the new health-care law going into effect this fall.
Ted Cruz has outlined a plan to defund Obamacare going forward, but he needs Republicans to stand up and ban together to vote to withdraw financial support of the health-care law.
Community Health Systems announced it would buy Health Management Associates in a deal valued at approximately $7.6 billion, including about $3.7 billion in debt.
Barbara Ryan, FTI Consulting, breaks down the second quarter numbers on Pfizer and Merck and provides an outlook on which companies have the best drugs in the pipeline.
Regardless of what narrative may ultimately prove to best explain GSK's current problems in China, doing business in the sector for multinationals will never be the same.
Merck reported second-quarter earnings on Tuesday that exceeded analysts' expectations, yet revenues fell on weak drug sales.
Pfizer reported earnings slightly ahead of forecasts, as the largest U.S. drugmaker lines up a business split that could lead to the spin-off of its generics division.
Using a technology that echoes science fiction, a company is offering people a place to store their stem cells in a bet that they may one day be used to grow replacement organs.
Both Pfizer and Merck are expected to report double-digit declines in top- and bottom-line growth when they announce earnings Tuesday.
U.S. generic drugmaker Perrigo agreed to buy fellow drug company Elan for $8.6 billion on Monday in a deal that will hand it royalty rights from a blockbuster treatment and tax savings from being domiciled in Ireland.
In a recent report, researchers found that blood pressure medication also functions to provide measurable relief for patients experiencing worsening Alzheimer's symptoms.
Had you bought this stock last week, you’d be pretty happy right now. How should you play it now?
Patients whose doctors sell their practices to hospitals could see prices rise, at least in the short term, experts say.
Biotech IPOs, after doing nothing for years, are suddenly hot. One came roaring out of the starting gate today, and several are pricing tonight.
More middle-age workers fear the financial consequences of a critical illness than fear dying from that illness, but few are preparing for that possibility, a survey finds.
Get the best of CNBC in your inbox